Skip to main content
. 2021 Aug;22(8):2587–2596. doi: 10.31557/APJCP.2021.22.8.2587

Table 3.

IC50 Values for the Drug Formulations against MDA-MB-231and MCF-7 Breast Cancer Cell Lines after 24, 48, 72 h Incubation Time

time (h) MDA-MB-231 MCF-7
SIL (µM) SIL- NPs SIL (µM) SIL- NPs
24 h 65.11 55.23 53.68 48.21
48 h 55.29 48.35 47.41 43.51
72 h 45.11 39.54 27.14 19.13